Cliff Asness's IRMD Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 15,889 shares of IRADIMED CORPORATION (IRMD) worth $1.55 M, representing 0.00% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 37 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in IRMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2016, adding 54,011 shares. Largest reduction occurred in Q3 2017, reducing 53,306 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's IRADIMED CORPORATION (IRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly IRADIMED CORPORATION (IRMD) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2,524 | Add 18.89% | 15,889 | $97.28 |
| Q3 2025 | +1,782 | Add 15.38% | 13,365 | $71.16 |
| Q2 2025 | -4,246 | Reduce 26.82% | 11,583 | $59.79 |
| Q1 2025 | +1,108 | Add 7.53% | 15,829 | $52.48 |
| Q4 2024 | +4,218 | Add 40.16% | 14,721 | $55.00 |
| Q3 2024 | +2,067 | Add 24.50% | 10,503 | $50.29 |
| Q2 2024 | +8,436 | New Buy | 8,436 | $43.94 |
| Q1 2024 | -4,667 | Sold Out | 0 | $0.00 |
| Q4 2023 | -5,096 | Reduce 52.20% | 4,667 | $47.47 |
| Q3 2023 | -16 | Reduce 0.16% | 9,763 | $44.37 |
| Q2 2023 | +9,779 | New Buy | 9,779 | $47.74 |
| Q4 2022 | -16,755 | Sold Out | 0 | $0.00 |
| Q3 2022 | -9,279 | Reduce 35.64% | 16,755 | $30.08 |
| Q2 2022 | +21,181 | Add 436.45% | 26,034 | $33.96 |
| Q1 2022 | +4,853 | New Buy | 4,853 | $44.92 |
| Q1 2021 | -10,377 | Sold Out | 0 | $0.00 |
| Q4 2020 | -20,459 | Reduce 66.35% | 10,377 | $22.84 |
| Q3 2020 | -8,691 | Reduce 21.99% | 30,836 | $21.37 |
| Q2 2020 | -11,675 | Reduce 22.80% | 39,527 | $23.20 |
| Q1 2020 | -5,895 | Reduce 10.32% | 51,202 | $21.35 |
| Q4 2019 | -18,667 | Reduce 24.64% | 57,097 | $23.38 |
| Q3 2019 | +51,793 | Add 216.07% | 75,764 | $21.03 |
| Q2 2019 | +8,207 | Add 52.06% | 23,971 | $20.44 |
| Q1 2019 | +6,673 | Add 73.40% | 15,764 | $28.10 |
| Q4 2018 | +9,091 | New Buy | 9,091 | $24.42 |
| Q3 2018 | -25,499 | Sold Out | 0 | $0.00 |
| Q2 2018 | -14,309 | Reduce 35.95% | 25,499 | $20.75 |
| Q1 2018 | -22,486 | Reduce 36.10% | 39,808 | $14.09 |
| Q4 2017 | -30,981 | Reduce 33.21% | 62,294 | $15.15 |
| Q3 2017 | -53,306 | Reduce 36.37% | 93,275 | $9.60 |
| Q2 2017 | +8,918 | Add 6.48% | 146,581 | $8.60 |
| Q1 2017 | +28,345 | Add 25.93% | 137,663 | $8.90 |
| Q4 2016 | +54,011 | Add 97.66% | 109,318 | $11.10 |
| Q3 2016 | +7,043 | Add 14.59% | 55,307 | $17.00 |
| Q2 2016 | +14,214 | Add 41.74% | 48,264 | $21.76 |
| Q1 2016 | +19,923 | Add 141.03% | 34,050 | $19.15 |
| Q4 2015 | +14,127 | New Buy | 14,127 | $28.03 |
Cliff Asness's IRADIMED CORPORATION Investment FAQs
Cliff Asness first purchased IRADIMED CORPORATION (IRMD) in Q4 2015, acquiring 14,127 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held IRADIMED CORPORATION (IRMD) for 37 quarters since Q4 2015.
Cliff Asness's largest addition to IRADIMED CORPORATION (IRMD) was in Q4 2016, adding 109,318 shares worth $1.21 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 15,889 shares of IRADIMED CORPORATION (IRMD), valued at approximately $1.55 M.
As of the Q4 2025 filing, IRADIMED CORPORATION (IRMD) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in IRADIMED CORPORATION (IRMD) was 146,581 shares, as reported at the end of Q2 2017.